Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis

Whether macrolide combination therapy reduces the mortality of patients with severe community-acquired pneumonia (CAP) hospitalized in the non-intensive care unit (ICU) remains unclear. Therefore, we investigated the efficacy of adding azithromycin to β-lactam antibiotics for such patients. This pro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2019-12, Vol.9 (1), p.18406-8, Article 18406
Hauptverfasser:	Ito, Akihiro, Ishida, Tadashi, Tachibana, Hiromasa, Tokumasu, Hironobu, Yamazaki, Akio, Washio, Yasuyoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	631/326/22/1290 692/699/255/1318 692/700/565/1436/2774 Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Antibiotics Azithromycin Azithromycin - therapeutic use Bacteremia - drug therapy Bacteremia - microbiology Bacteremia - mortality Bacteremia - pathology beta-Lactams - therapeutic use Community-Acquired Infections Drug Therapy, Combination Female Health risk assessment Humanities and Social Sciences Humans Infectious diseases Male Mortality multidisciplinary Pneumonia Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Pneumonia, Bacterial - mortality Pneumonia, Bacterial - pathology Prospective Studies Science Science (multidisciplinary) Severity of Illness Index Survival Analysis Thorax β-Lactam antibiotics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!